BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Puhalla H, Gruenberger T, Pokorny H, Soliman T, Wrba F, Sponer U, Winkler T, Ploner M, Raderer M, Steininger R. Resection of hilar cholangiocarcinomas: pivotal prognostic factors and impact of tumor sclerosis. World J Surg. 2003;27:680-684. [PMID: 12733000 DOI: 10.1007/s00268-003-6656-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Malikowski T, Levy MJ, Gleeson FC, Storm AC, Vargas EJ, Topazian MD, Abu Dayyeh BK, Iyer PG, Rajan E, Gores GJ, Roberts LR, Chandrasekhara V. Endoscopic Ultrasound/Fine Needle Aspiration Is Effective for Lymph Node Staging in Patients With Cholangiocarcinoma. Hepatology 2020;72:940-8. [PMID: 31860935 DOI: 10.1002/hep.31077] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
2 Gao Y, Xu D, Wu YS, Chen D, Xiong W. Increasing negative lymph node count is independently associated with improved long-term survival in resectable perihilar cholangiocarcinomas. Medicine (Baltimore) 2019;98:e14943. [PMID: 30985643 DOI: 10.1097/MD.0000000000014943] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
3 Lin H, Wu YS, Li Z, Jiang Y. Prognostic value of retrieved lymph node counts in patients with node-negative perihilar cholangiocarcinomas. ANZ J Surg 2018;88:E829-34. [PMID: 30207026 DOI: 10.1111/ans.14775] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
4 Abd ElWahab M, El Nakeeb A, El Hanafy E, Sultan AM, Elghawalby A, Askr W, Ali M, Abd El Gawad M, Salah T. Predictors of long term survival after hepatic resection for hilar cholangiocarcinoma: A retrospective study of 5-year survivors. World J Gastrointest Surg 2016; 8(6): 436-443 [PMID: 27358676 DOI: 10.4240/wjgs.v8.i6.436] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
5 Gomez D, Patel P, Lacasia-purroy C, Byrne C, Sturgess R, Palmer D, Fenwick S, Poston G, Malik H. Impact of specialized multi-disciplinary approach and an integrated pathway on outcomes in hilar cholangiocarcinoma. European Journal of Surgical Oncology (EJSO) 2014;40:77-84. [DOI: 10.1016/j.ejso.2013.10.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
6 Levy MJ, Heimbach JK, Gores GJ. Endoscopic ultrasound staging of cholangiocarcinoma. Curr Opin Gastroenterol. 2012;28:244-252. [PMID: 22274618 DOI: 10.1097/mog.0b013e32835005bc] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 4.4] [Reference Citation Analysis]
7 Connor S, Wigmore SJ, Madhavan KK, Parks RW, Garden OJ. Surgical palliation for unresectable hilar cholangiocarcinoma. HPB (Oxford) 2005;7:273-7. [PMID: 18333206 DOI: 10.1080/13651820500372442] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
8 Guglielmi A, Ruzzenente A, Campagnaro T, Pachera S, Valdegamberi A, Capelli P, Pedica F, Nicoli P, Conci S, Iacono C. Does intrahepatic cholangiocarcinoma have better prognosis compared to perihilar cholangiocarcinoma? J Surg Oncol 2010;101:111-5. [PMID: 19953578 DOI: 10.1002/jso.21452] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
9 Ojima H, Kanai Y, Iwasaki M, Hiraoka N, Shimada K, Sano T, Sakamoto Y, Esaki M, Kosuge T, Sakamoto M, Hirohashi S. Intraductal carcinoma component as a favorable prognostic factor in biliary tract carcinoma. Cancer Sci 2009;100:62-70. [PMID: 19038006 DOI: 10.1111/j.1349-7006.2008.01009.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
10 Gleeson FC, Rajan E, Levy MJ, Clain JE, Topazian MD, Harewood GC, Papachristou GI, Takahashi N, Rosen CB, Gores GJ. EUS-guided FNA of regional lymph nodes in patients with unresectable hilar cholangiocarcinoma. Gastrointest Endosc. 2008;67:438-443. [PMID: 18061597 DOI: 10.1016/j.gie.2007.07.018] [Cited by in Crossref: 96] [Cited by in F6Publishing: 82] [Article Influence: 6.4] [Reference Citation Analysis]
11 Lang H. Erweiterte multimodale Leberresektionen bei primären und sekundären Lebertumoren. Visc Med 2007;23:340-6. [DOI: 10.1159/000109996] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
12 Connor S, Barron E, Redhead D, Ireland H, Madhavan K, Parks R, Garden O. Palliation for suspected unresectable hilar cholangiocarcinoma. European Journal of Surgical Oncology (EJSO) 2007;33:341-5. [DOI: 10.1016/j.ejso.2006.11.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
13 Otto G. Diagnostic and surgical approaches in hilar cholangiocarcinoma. Int J Colorectal Dis 2007;22:101-8. [PMID: 16575606 DOI: 10.1007/s00384-005-0070-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
14 Lafrenière R. What’s new in general surgery: surgical oncology. Journal of the American College of Surgeons 2004;198:966-88. [DOI: 10.1016/j.jamcollsurg.2004.03.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]